New Tau PET Tracer Offers Early Alzheimer’s Detection with Precision
A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer’s disease in its earliest stages.
Tag: Alzheimer’s disease
All
Latest
All
Latest
MITA Responds to Proposed Coverage Decision for Monoclonal Antibodies Directed Against Amyloid
The Medical Imaging & Technology Alliance (MITA) has submitted comments in response to the Centers for Medicare & Medicaid Services Proposed Decision Memorandum for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease.
All
Latest
New PET Tracer Detects Hallmark of Alzheimer’s Disease Years Before Symptoms Emerge
A novel PET radiotracer has been shown to effectively measure increases in brain tau—a distinguishing characteristic of Alzheimer’s disease—before any symptoms of the disease are observed.
Imaging Probe to Visualize Alzheimer’s Disease-Related Gamma-Secretase in the Brain
Scientists at the Massachusetts General Hospital have developed a molecular imaging probe to reveal Alzheimer’s disease-related γ-secretase in rodents and macaques with translational potentials in humans.
Read More
Brain Iron Accumulation Linked to Cognitive Decline in Alzheimer’s Patients
Researchers using MRI have found that iron accumulation in the outer layer of the brain is associated with cognitive deterioration in people with Alzheimer’s disease, according to a new study.
Read More
Retinal Texture Could Provide Early Biomarker of Alzheimer’s Disease
A new imaging device capable of measuring both the thickness and texture of the retina could be used to detect a biomarker of Alzheimer’s disease.
Read More
FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
The approval marks a significant advance toward a more definitive assessment of Alzheimer’s based on brain imaging.
Read More
A Positive Amyloid PET Scan Identifies Subtle Cognitive Problems in Asymptomatic Adults
PET scans done as part of the A4 study showed elevated amyloid burden and subtle cognitive deficits in adults who were asymptomatic for Alzheimer’s disease.
Read More